These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25773566)

  • 1. Mapping the clinical chronic obstructive pulmonary disease questionnaire onto generic preference-based EQ-5D values.
    Boland MR; van Boven JF; Kocks JW; van der Molen T; Goossens LM; Chavannes NH; Rutten-van Mölken MP
    Value Health; 2015 Mar; 18(2):299-307. PubMed ID: 25773566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A; Green C; Telford C; Zajicek J; Wright D
    Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.
    Wong CKH; Cheung PWH; Samartzis D; Luk KD; Cheung KMC; Lam CLK; Cheung JPY
    PLoS One; 2017; 12(4):e0175847. PubMed ID: 28414745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting EQ-5D values using the SGRQ.
    Starkie HJ; Briggs AH; Chambers MG; Jones P
    Value Health; 2011; 14(2):354-60. PubMed ID: 21402304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the FACT-P to the preference-based EQ-5D questionnaire in metastatic castration-resistant prostate cancer.
    Skaltsa K; Longworth L; Ivanescu C; Phung D; Holmstrom S
    Value Health; 2014 Mar; 17(2):238-44. PubMed ID: 24636382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values.
    Hernández Alava M; Wailoo AJ; Ara R
    Value Health; 2012 May; 15(3):550-61. PubMed ID: 22583466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the COPD Assessment Test onto EQ-5D.
    Hoyle CK; Tabberer M; Brooks J
    Value Health; 2016 Jun; 19(4):469-77. PubMed ID: 27325339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D utility scores.
    Kay S; Ferreira A
    Ophthalmic Epidemiol; 2014 Apr; 21(2):66-78. PubMed ID: 24568628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping analysis to estimate EQ-5D utility values using the COPD assessment test in Korea.
    Lim J; Choi SE; Bae E; Kang D; Lim EA; Shin GS
    Health Qual Life Outcomes; 2019 Jun; 17(1):97. PubMed ID: 31170982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of FACT- and EQ-5D-based utility scores in cancer.
    Pickard AS; Ray S; Ganguli A; Cella D
    Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping from disease-specific measures to health-state utility values in individuals with migraine.
    Gillard PJ; Devine B; Varon SF; Liu L; Sullivan SD
    Value Health; 2012 May; 15(3):485-94. PubMed ID: 22583459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a preference-based measure of health (EQ-5D) in COPD and asthma.
    Pickard AS; Wilke C; Jung E; Patel S; Stavem K; Lee TA
    Respir Med; 2008 Apr; 102(4):519-36. PubMed ID: 18180151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: assessing the external validity of existing mapping algorithms.
    Doble B; Lorgelly P
    Qual Life Res; 2016 Apr; 25(4):891-911. PubMed ID: 26391884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chinese time trade-off values for EQ-5D health states.
    Liu GG; Wu H; Li M; Gao C; Luo N
    Value Health; 2014 Jul; 17(5):597-604. PubMed ID: 25128053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of health state in patients with tinnitus: a comparison of the EQ-5D and HUI mark III.
    Maes IH; Joore MA; Cima RF; Vlaeyen JW; Anteunis LJ
    Ear Hear; 2011; 32(4):428-35. PubMed ID: 21221004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
    Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F;
    Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities.
    Wacker ME; Jörres RA; Karch A; Wilke S; Heinrich J; Karrasch S; Koch A; Schulz H; Watz H; Leidl R; Vogelmeier C; Holle R;
    BMC Pulm Med; 2016 May; 16(1):70. PubMed ID: 27160582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping CushingQOL scores to EQ-5D utility values using data from the European Registry on Cushing's syndrome (ERCUSYN).
    Badia X; Roset M; Valassi E; Franz H; Forsythe A; Webb SM
    Qual Life Res; 2013 Dec; 22(10):2941-50. PubMed ID: 23539468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the EORTC-QLQ-C30 to the EQ-5D-3L: An Assessment of Existing and Newly Developed Algorithms.
    Woodcock F; Doble B;
    Med Decis Making; 2018 Nov; 38(8):954-967. PubMed ID: 30226101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.